MCDERMOTT+

Lobbying for 340B HEALTH · Association focusing on the 340B drug pricing program

Filing 3rd Quarter - Termination

3rd Quarter (July 1 - Sep 30) 2026 · District of Columbia · House · Senate · $30,000.00 income · posted Aug 28, 2026

Lobbying activity 2

Health Issues

Issues relating to the 340B Drug Pricing Program.

Medicare/Medicaid

Issues relating to the 340B Drug Pricing Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.